Infigratinib in Patients With Recurrent Gliomas and FGFR Alterations
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Infigratinib in Patients with Recurrent Gliomas and FGFR Alterations: A Multicenter Phase II Study
Clin. Cancer Res 2022 Mar 28;[EPub Ahead of Print], AB Lassman, JM Sepúlveda-Sánchez, T Cloughesy, MJ Gil-Gil, VK Puduvalli, J Raizer, FYF De Vos, PY Wen, N Butowski, PMJ Clement, MD Groves, C Belda-Iniesta, P Giglio, HS Soifer, S Rowsey, C Xu, F Avogadri, G Wei, S Moran, P RothFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Brain Cancer Center of Excellence
Visit our Brain Cancer Center of Excellence for additional, in-depth coverage.